QuantLogix

MRNA vs PFE — live signal comparison

Head-to-head on QuantLogix's 5-factor quant engine, recomputed throughout the trading day. An engine-read comparison — not a recommendation.

engine lead
MRNA
Moderna, Inc. Common Stock
69/100
BUY
$143.97 · +5.88% · $57.5B
Full scorecard →
VS
PFE
Pfizer Inc.
65/100
BUY
$27.72 · +0.30% · $158.0B
50% of similar setups up in 5d
Full scorecard →
Factor by factor — MRNA (left) vs PFE (right)
63
Technical
65
75
Momentum
58
40
Fundamental
51
69
Options
44
73
Microstructure
60

QuantLogix's 5-factor engine currently reads Moderna, Inc. Common Stock (MRNA) at 69/100 (buy) and Pfizer Inc. (PFE) at 65/100 (buy). MRNA carries the stronger composite read by 4 points, led by momentum at 75/100. PFE's strongest leg is technical at 65/100. Signals recompute throughout the trading day — the balance can shift with the tape.

Track MRNA with free signal alerts Browse all scorecards
🤖 Want the deeper take? Pro runs a 10-agent AI debate on either name — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Educational market analysis, not investment advice. QuantLogix does not provide personalized recommendations. MRNA scorecard · PFE scorecard · MRNA earnings · PFE earnings · Today's movers · Verified track record